USDA investigates unapproved GMO wheat found in Washington state

CHICAGO (Reuters) – The U.S. Department of Agriculture has confirmed the discovery of unapproved, genetically modified (GM) wheat plants growing in an un-planted agricultural field in Washington state.

There was no evidence the wheat had entered the food supply, the USDA’s Animal and Plant Health Inspection Service said in a statement on Friday. The wheat is resistant to glyphosate, a widely used herbicide commonly referred to as Roundup.

“USDA is collaborating with our state, industry and trading partners, and we are committed to providing all our partners with timely and transparent information about our findings,” the statement said.

There are currently no commercially approved genetically modified wheat varieties, and incidences of rogue plants are rare. However, unapproved plants were found in 2018 in Alberta, Canada, in 2016 in Washington state, in 2014 in Montana and in 2013 in Oregon.

A Bayer Crop Science spokeswoman said the latest finding may have occurred on the site of a former field trial. Last year Bayer bought Monsanto, which in the late 1990s and early 2000s developed wheat genetically modified to withstand its Roundup herbicide, a weed killer containing glyphosate.

Monsanto shelved the genetically engineered wheat in 2004 amid market concern about rejection from foreign buyers. The United States was the world’s second-largest wheat exporter after Russia in the 2018/19 marketing year.

“We have been informed by USDA of a possible detection of GM wheat in Washington State, possibly on the site of a former field trial,” Bayer Crop Sciences spokeswoman Charla Lord said.

“We are cooperating with USDA to gather more information and facts as the agency reviews the situation,” Lord said.

Samples of the wheat plants from the field in Washington were sent to the USDA’s Federal Grain Inspection Service lab in Kansas City, Missouri, as well as a USDA lab in Pullman, Washington, for testing and confirmation, according to a joint statement from the National Association of Wheat Growers and U.S. Wheat Associates, a trade group that promotes U.S. wheat sales.

Bayer, which inherited litigation over Roundup with its $63 billion acquisition of Monsanto last year, faces lawsuits by more than 13,400 plaintiffs in the United States, alleging the product causes cancer.

A California jury last month awarded more than $2 billion to a couple who claimed Roundup caused their non-Hodgkin’s lymphoma. It was the largest U.S. jury verdict to date against the company in litigation over the chemical.

Additional reporting by Tom Polansek in Chicago; Editing by Sandra Maler

Source

more recommended stories

  • South Africa to roll out sweeping health reform in stages

    PRETORIA (Reuters) – A proposed move.

  • FDA classifies Edwards Lifesciences Sapien delivery system recall as severest

    (Reuters) – The U.S. Food and.

  • Plastic particles in drinking water present ‘low’ risk: WHO

    GENEVA (Reuters) – Microplastics contained in.

  • AstraZeneca’s Imfinzi misses main goal of advanced lung cancer study

    FILE PHOTO: A sign is seen.

  • AstraZeneca diabetes drug shows promise in heart failure

    (Reuters) – AstraZeneca (AZN.L) made strides.

  • Study prompts call for lower fluoride consumption by pregnant women

    (Reuters Health) – Adding fluoride to.

  • CDC investigates lung illnesses linked to e-cigarette use

    FILE PHOTO: A man vapes outside.

  • E.coli in water forces Tokyo to cancel swimming at Paratriathlon World Cup

    TOKYO (Reuters) – High levels of.

  • E.coli risk forces Tokyo to cancel swim events at Paratriathlon World Cup

    TOKYO (Reuters) – High levels of.

  • First two Ebola cases confirmed in Congo’s South Kivu – officials

    FILE PHOTO: Children look at a.

  • Surgical training programs not supportive of new parents

    (Reuters Health) – Surgical residents say.

  • Liver disease related to obesity and diabetes rising in U.S.

    (Reuters Health) – The only liver.

  • Ebola ‘no longer incurable’ as Congo trial finds drugs boost survival

    LONDON (Reuters) – Scientists are a.

  • Scientists hail promise of first effective Ebola treatments in Congo trial

    LONDON (Reuters) – Scientists are a.

  • China cuts 2019/20 corn use forecast by 2 million tonnes due to African swine fever

    Corn kernels are seen at a.

  • WHO says no new Ebola cases in Goma, vaccinates over 1,300

    FILE PHOTO: A young woman reacts.

  • Dengue death toll rises in Malaysia, number of cases close to double

    KUALA LUMPUR (Reuters) – Malaysia saw.

  • Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis

    (Reuters) – A U.S. judge on.

  • AstraZeneca’s Tagrisso helps lung cancer patients live longer: study

    (Reuters) – AstraZeneca Plc said on.

  • Study shows Apple devices in combo with apps could identify dementia

    FILE PHOTO: The new Apple iPhone.

  • Moving during early pregnancy may increase preterm birth risk

    (Reuters Health) – Moving to a.

  • Drug assistance programs offer little charity to uninsured

    (Reuters Health) – Many patients who.

  • In extreme heat, electric fans inadvisable unless it’s humid

    In extreme heat, electric fans may.

  • Trump administration considers September unveiling of healthcare plan: WSJ

    FILE PHOTO: U.S. President Donald Trump.

  • Bulgaria to compensate owners who cull pigs to help stamp out swine fever

    FILE PHOTO: A pig rests at.

  • Yellow lens glasses don’t improve drivers’ night vision

    (Reuters Health) – – Touted to.

  • U.S. FDA approves Daiichi Sankyo’s treatment for rare joint tumor

    (Reuters) – The U.S. Food and.

  • For some surgeries, hospital rankings not tied to better outcomes

    (Reuters Health) – When it comes.

  • Congo says Rwanda has closed border near Goma

    Congolese customs agents gather at the.

  • Pluristem gets positive results from radiation treatment trials

    TEL AVIV (Reuters) – Israel’s Pluristem Therapeutics.

  • Congress seeks briefing on potential threat to U.S. heparin supply

    WASHINGTON (Reuters) – Leaders of the.

  • U.S. judge blocks Medicaid work requirements in New Hampshire

    (Reuters) – A federal judge on.